U.S. market Closed. Opens in 7 hours 13 minutes

RPRX | Royalty Pharma plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue2.35B2.24B2.29B2.12B1.81B1.79B1.60B1.88B1.65B
Cost of Revenue560.66M5.67M23.00M88.11M1.02B135.96M33.27MN/AN/A
Gross Profit1.79B2.23B2.27B2.03B794.93M1.66B1.56B1.88B1.65B
Operating Expenses862.40M1.31B858.75M527.00M-808.92M430.45M658.24M1.09B789.98M
Selling, General & Admin249.75M227.30M182.83M182.00M103.44M61.91M106.44M69.51M121.42M
Research & Development52.00M177.11M200.08M26.00M83.04M392.61M117.87M91.02M98.38M
Other Operating Expenses560.66M909.91M475.84M319.00M-995.40M-1.52M-1.62M-925.80M-570.18M
Operating Income1.49B977.50M1.43B1.59B2.62B1.36B939.69M722.87M794.28M
Other Expenses / Income207.94M-77.00M-189.51M106.56M-161.76M153.41M403.49M39.02M-35.57M
Before Tax Income1.70B230.06M1.24B1.70B2.46B1.52B1.34B761.89M758.71M
Income Tax ExpensesN/A187.23M762.45M1.15B349.33M433.37M542.65M195.99M177.28M
Net Income1.13B42.83M478.75M495.20M2.35B1.38B1.21B565.91M581.43M
Interest Expenses187.19M187.96M166.14M157.00M268.57M279.96M247.34M238.91M224.42M
Basic Shares Outstanding447.60M437.96M414.79M375.44M365.90M354.18M354.18M607.04M607.04M
Diluted Shares Outstanding602.90M437.97M414.80M375.45M365.90M354.18M354.18M607.04M607.04M
EBITDA1.89B928.56M1.45B1.68B2.65B1.40B972.96M1.07B862.44M
EBITDA Margin80.15%41.51%63.50%79.34%145.91%77.87%60.89%56.94%52.19%
EBIT1.32B418.02M1.41B1.80B2.97B2.09B2.00B1.00B983.13M
EBIT Margin56.15%18.69%61.47%84.79%163.51%116.50%125.16%53.31%59.50%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙